Further research, which separated the heterogeneous aPL population from APS patients into different subpopulations, showed that anti-β2GPI antibodies significantly enhanced the thrombotic response in a mouse model (36). The gene discussed is APOH; the disease is autoimmune polyendocrinopathy.